Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Halsey

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Malaria Journal|December 25, 2021
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in UgandaChris Ebong, Asadu Sserwanga, Jane Frances Namuganga, et al.
Emerging Infectious Diseases|November 21, 2017
Capacity Development through the US President's Malaria Initiative-Supported Antimalarial Resistance Monitoring in Africa NetworkEric S Halsey, Meera Venkatesan, Mateusz M Plucinski, et al.
Malaria Journal|February 8, 2022
Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in UgandaChris Ebong, Asadu Sserwanga, Jane Frances Namuganga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2018
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)Jonathan Welti, Adam Sharp, Wei Yuan, et al.
Malaria Journal|June 12, 2025
Plasmodium falciparum multidrug resistance 1 gene polymorphisms associated with outcomes after anti-malarial treatmentVeronika R Laird, Mateusz M Plucinski, Meera Venkatesan, et al.
The American Journal of Tropical Medicine and Hygiene|September 7, 2021
Therapeutic Efficacy of Artemisinin-Based Combination Therapies in Democratic Republic of the Congo and Investigation of Molecular Markers of Antimalarial ResistanceLeah F Moriarty, Papy Mandoko Nkoli, Joris Losimba Likwela, et al.
The Lancet. Infectious Diseases|April 17, 2021
Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy studyAline Uwimana, Noella Umulisa, Meera Venkatesan, et al.
Emerging Infectious Diseases|June 21, 2021
Plasmodium falciparum kelch 13 Mutations, 9 Countries in Africa, 2014-2018Sarah E Schmedes, Dhruviben Patel, Simran Dhal, et al.
Journal of the American Heart Association|May 11, 2017
Activation of the Amino Acid Response Pathway Blunts the Effects of Cardiac StressPu Qin, Pelin Arabacilar, Roberta E Bernard, et al.
Malaria Journal|March 9, 2024
Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021Catherine Bakari, Celine I Mandara, Rashid A Madebe, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Malaria Journal|December 25, 2021
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in UgandaChris Ebong, Asadu Sserwanga, Jane Frances Namuganga, et al.
Emerging Infectious Diseases|November 21, 2017
Capacity Development through the US President's Malaria Initiative-Supported Antimalarial Resistance Monitoring in Africa NetworkEric S Halsey, Meera Venkatesan, Mateusz M Plucinski, et al.
Malaria Journal|February 8, 2022
Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in UgandaChris Ebong, Asadu Sserwanga, Jane Frances Namuganga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2018
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)Jonathan Welti, Adam Sharp, Wei Yuan, et al.
Malaria Journal|June 12, 2025
Plasmodium falciparum multidrug resistance 1 gene polymorphisms associated with outcomes after anti-malarial treatmentVeronika R Laird, Mateusz M Plucinski, Meera Venkatesan, et al.
The American Journal of Tropical Medicine and Hygiene|September 7, 2021
Therapeutic Efficacy of Artemisinin-Based Combination Therapies in Democratic Republic of the Congo and Investigation of Molecular Markers of Antimalarial ResistanceLeah F Moriarty, Papy Mandoko Nkoli, Joris Losimba Likwela, et al.
The Lancet. Infectious Diseases|April 17, 2021
Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy studyAline Uwimana, Noella Umulisa, Meera Venkatesan, et al.
Emerging Infectious Diseases|June 21, 2021
Plasmodium falciparum kelch 13 Mutations, 9 Countries in Africa, 2014-2018Sarah E Schmedes, Dhruviben Patel, Simran Dhal, et al.
Journal of the American Heart Association|May 11, 2017
Activation of the Amino Acid Response Pathway Blunts the Effects of Cardiac StressPu Qin, Pelin Arabacilar, Roberta E Bernard, et al.
Malaria Journal|March 9, 2024
Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021Catherine Bakari, Celine I Mandara, Rashid A Madebe, et al.
Pageof 15